Latest Infectious Disease Articles

• Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria April 26, 2024
  Malaria is a major cause of illness worldwide. In a phase 2 trial in Mali, one subcutaneous dose of L9LS, a monoclonal antibody targeting Plasmodium falciparum, reduced the incidence of clinical malaria among children.
  Kassoum Kayentao, Aissata Ongoiba, Anne C. Preston, Sara A. Healy, Zonghui Hu, Jeff Skinner, Safiatou Doumbo, Jing Wang, Hamidou Cisse, Didier Doumtabe, Abdrahamane Traore, Hamadi Traore, Adama Djiguiba, Shanping Li, Mary E. Peterson, Shinyi Telscher, Azza H. Idris, William C. Adams, Adrian B. McDermott, Sandeep Narpala, Bob C. Lin, Leonid Serebryannyy, Somia P. Hickman, Andrew J. McDougal, Sandra Vazquez, Matthew Reiber, Judy A. Stein, Jason G. Gall, Kevin Carlton, Philipp Schwabl, Siriman Traore, Mamadou Keita, Amatigué Zéguimé, Adama Ouattara, M’Bouye Doucoure, Amagana Dolo, Sean C. Murphy, Daniel E. Neafsey, Silvia Portugal, Abdoulaye Djimdé, Boubacar Traore, Robert A. Seder, Peter D. Crompton, the Mali Malaria mAb Trial Team*
• The Quest for Transformative Tools to Eradicate Malaria April 26, 2024
  We in the global malaria community are at a critical juncture in our journey toward malaria eradication. Decades of experience in deploying our existing interventions have made it clear that there is no single “silver bullet.” Rather, driving down morbidity and mortality requires that we use combinations of interventions across...
  Trevor Mundel
• Outbreak of Listeriosis Associated with Consumption of Vegan Cheese April 18, 2024
  Plant-based cheeses are marketed as safe alternatives to raw-milk cheese for populations at high risk for foodborne infection. Listeriosis cases in Europe, including in pregnancy, were linked to consumption of vegan cheese.
  Alexandre Leclercq, Mathieu Tourdjman, Wesley Mattheus, Ingrid Friesema, Nina M. van Sorge, Sven Halbedel, Hendrik Wilking, Marc Lecuit